Shay Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Shay Capital’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30,000	Closed	-$428K	–	460
2023 Q4	$428K	Buy	+30,000	New	+$426K	0.09%	148

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Shay Capital's SBRA Position: Q1 2024 in Review

Shay Capital sold out of Sabra Healthcare REIT (SBRA) in Q1 2024, closing a stake of 30,000 shares — an estimated $428K sold.

Shay Capital first reported a position in SBRA in Q4 2023 and held it in 1 quarter. The position peaked at $428K in Q4 2023. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.

Shay Capital reported no remaining Sabra Healthcare REIT position as of Q1 2024 after selling out during the quarter.
Shay Capital sold 30,000 Sabra Healthcare REIT shares in Q1 2024, an estimated $428K.
Shay Capital first reported a position in Sabra Healthcare REIT in Q4 2023 and held it in 1 quarter.
Shay Capital's Sabra Healthcare REIT position peaked at $428K in Q4 2023.
342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.

Based on Shay Capital's 13F filing for Q1 2024, filed 15 May 2024.